Geneos Wealth Management’s AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF SIXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SIXP
A
BCM
FCM
PFGIA
KAS
Geneos Wealth Management's SIXP Position: Q2 2026 in Review
Geneos Wealth Management held its AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF (SIXP) position steady in Q2 2026 at 548 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1829.
Geneos Wealth Management first reported a position in SIXP in Q3 2025 and has held it in 4 quarters since. The position peaked at $24.2K in Q3 2025. 24 funds tracked by Wall St. Rank hold SIXP as of Q2 2026.
- Geneos Wealth Management held 548 shares of AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF worth $18.5K as of Q2 2026.
- Geneos Wealth Management left its AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF share count unchanged in Q2 2026.
- AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1829 holding.
- Geneos Wealth Management first reported a position in AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF in Q3 2025 and has held it in 4 quarters since.
- Geneos Wealth Management's AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position peaked at $24.2K in Q3 2025.
- 24 funds tracked by Wall St. Rank held AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.